tiprankstipranks
Advertisement
Advertisement
ITRM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsITRM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Iterum Therapeutics cut to Hold at Maxim after delisting notice
Premium
The Fly
Iterum Therapeutics cut to Hold at Maxim after delisting notice
3M ago
Iterum Therapeutics downgraded to Hold from Buy at Maxim
Premium
The Fly
Iterum Therapeutics downgraded to Hold from Buy at Maxim
3M ago
Iterum Therapeutics Shareholders Reject Key Capital Proposals
PremiumCompany AnnouncementsIterum Therapeutics Shareholders Reject Key Capital Proposals
4M ago
Iterum provides business update, expanded market access for Orlynvah
Premium
The Fly
Iterum provides business update, expanded market access for Orlynvah
4M ago
Iterum Therapeutics provides market access update
Premium
The Fly
Iterum Therapeutics provides market access update
6M ago
Iterum Therapeutics receives 510(k) clearance for Susceptibility Test Disc
PremiumThe FlyIterum Therapeutics receives 510(k) clearance for Susceptibility Test Disc
7M ago
Buy Rating Maintained for Iterum Therapeutics Despite Initial Challenges, Driven by Unique Market Position of ORLYNVAH
Premium
Ratings
Buy Rating Maintained for Iterum Therapeutics Despite Initial Challenges, Driven by Unique Market Position of ORLYNVAH
7M ago
Iterum Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Iterum Therapeutics Reports Q3 2025 Financial Results
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100